quarterly report is only a few weeks away, and following that the august cut off date for dividends in September. I dont mind re-interating that the IPO price of 20c is easily in sight. (pe 7 on 3.5 eps) probably 4c EPS. hence 28c achievable
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%